Evoke Pharma Inc. (EVOK)

[cash_cow1]

Guys don't forget to load up stock EVOK. My dad says 1 to 15 days left before Evoke Pharma Inc re-submission NDA for Gimoti. Gimoti is a safe Nasal spray form of metroclopramide a drug use to treat symptoms of Gastroparesis. Most patients suffering from Gastroparesis usually are patients with diabetes and 85% of the patients with Gastroparesis are women. When FDA approve Gimoti it will be the most advance treatment for Gastroparesis suffers in over 40 years.The re-submission will take place anytime from December 17 through December 31st, within 15 days from now. Good Luck.